• Explore /
  • Poster
  • / Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence.

Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence.

Abstract Poster

Authors

null

Maria Vittoria Dieci

Department of Oncology, Hematology and Respiratory Diseases, Modena University Hospital, Modena, Italy

Maria Vittoria Dieci , Elena Barbieri , Aicha Goubar , Fabrice Andre , Claudia Omarini , Stefania Raffaella Bettelli , Federico Piacentini , Guido Ficarra , Pier Franco Conte , Valentina Guarneri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

ER+

Citation

J Clin Oncol 31, 2013 (suppl; abstr 556)

DOI

10.1200/jco.2013.31.15_suppl.556

Abstract #

556

Poster Bd #

3C

Abstract Disclosures

Similar Posters

First Author: Melissa Chan

First Author: Frederique Madeleine Penault-Llorca

First Author: Francisco Emilio Vera-Badillo

Poster

2013 Breast Cancer Symposium

Recurrence score across the age spectrum: Is there an age discrimination?

Recurrence score across the age spectrum: Is there an age discrimination?

First Author: Franz Omar Smith